RS50591B - Lek za lečenje gljivičnih infekcija, naročito aspergiloze - Google Patents

Lek za lečenje gljivičnih infekcija, naročito aspergiloze

Info

Publication number
RS50591B
RS50591B RSP-2008/0316A RSP20080316A RS50591B RS 50591 B RS50591 B RS 50591B RS P20080316 A RSP20080316 A RS P20080316A RS 50591 B RS50591 B RS 50591B
Authority
RS
Serbia
Prior art keywords
medicament
treatment
fungal infections
aspergillosis
particularly aspergillosis
Prior art date
Application number
RSP-2008/0316A
Other languages
English (en)
Inventor
Giovanni Salvatori
Paolo Carminati
Luigina Romani
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of RS50591B publication Critical patent/RS50591B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Kombinacija pentraksina PTX3 sa antigljivičnim agensom. Prijava sadrži još 7 patentnih zahteva.
RSP-2008/0316A 2004-05-07 2005-04-28 Lek za lečenje gljivičnih infekcija, naročito aspergiloze RS50591B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000223A ITRM20040223A1 (it) 2004-05-07 2004-05-07 Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.
PCT/IT2005/000247 WO2005107791A1 (en) 2004-05-07 2005-04-28 Medicament for the treatment of fungal infections, particularly aspergillosis

Publications (1)

Publication Number Publication Date
RS50591B true RS50591B (sr) 2010-05-07

Family

ID=34968212

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2008/0316A RS50591B (sr) 2004-05-07 2005-04-28 Lek za lečenje gljivičnih infekcija, naročito aspergiloze

Country Status (25)

Country Link
US (2) US8778389B2 (sr)
EP (1) EP1750744B1 (sr)
JP (1) JP5574565B2 (sr)
KR (1) KR101192611B1 (sr)
CN (1) CN1950104B (sr)
AR (1) AR048775A1 (sr)
AT (1) ATE397937T1 (sr)
AU (1) AU2005239913B2 (sr)
BR (1) BRPI0510718A (sr)
CA (1) CA2563400C (sr)
CY (1) CY1108332T1 (sr)
DE (1) DE602005007485D1 (sr)
DK (1) DK1750744T3 (sr)
ES (1) ES2306145T3 (sr)
HK (1) HK1103961A1 (sr)
HR (1) HRP20080413T3 (sr)
IT (1) ITRM20040223A1 (sr)
ME (1) ME02743B (sr)
MX (1) MXPA06012889A (sr)
PL (1) PL1750744T3 (sr)
PT (1) PT1750744E (sr)
RS (1) RS50591B (sr)
SI (1) SI1750744T1 (sr)
TW (1) TWI393569B (sr)
WO (1) WO2005107791A1 (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
ITMI20062448A1 (it) * 2006-12-19 2008-06-20 Univ Degli Studi Modena E Reggio Emilia Metodo per la diagnosi e/o il monitoraggio dell¿ aspergillosi invasiva
US8838152B2 (en) 2007-11-30 2014-09-16 Microsoft Corporation Modifying mobile device operation using proximity relationships
CN101280326B (zh) * 2008-05-14 2011-07-06 中国科学院微生物研究所 一种抑制烟曲霉活性的化合物制备方法及其应用
EP2865384B1 (en) * 2012-06-22 2018-08-15 The University of Tokyo Agent for treating or preventing systemic inflammatory response syndrome
US20210349089A1 (en) * 2018-06-01 2021-11-11 B.R.A.H.M.S Gmbh Biomarkers for the diagnosis of invasive fungal infections
EP3669885A1 (en) * 2018-12-20 2020-06-24 Humanitas Mirasole S.p.A. Use of sap for the treatment of eurotiomycetes fungi infections
CN113952401B (zh) * 2021-12-15 2022-10-25 河北农业大学 一种用于防治畜禽曲霉菌感染的中药及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
JP2001183375A (ja) 1999-12-27 2001-07-06 Tosoh Corp 酵素標識抗体
WO2005026195A1 (en) * 2003-09-12 2005-03-24 Board Of Regents, The University Of Texas System Biopanning as an approach to study the pathogenesis of and produce novel treatment modalities for invasive aspergillosis
EP1730095A4 (en) * 2004-03-29 2008-04-02 Univ Mississippi NEW CYCLOPENTENDION COMPOUNDS ACTING AGAINST MUSHROOMS AND METHOD FOR THEIR APPLICATION
ITRM20040489A1 (it) 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
MX2008013872A (es) 2006-05-02 2008-11-14 Sigma Tau Ind Farmaceuti Uso de timosina alfa 1, sola o en combinacion con ptx3 o ganciclovir, para el tratamiento de infeccion por citomegalovirus.

Also Published As

Publication number Publication date
HRP20080413T3 (en) 2008-10-31
AR048775A1 (es) 2006-05-24
DK1750744T3 (da) 2008-09-29
US20140296135A1 (en) 2014-10-02
TWI393569B (zh) 2013-04-21
KR20070007375A (ko) 2007-01-15
JP5574565B2 (ja) 2014-08-20
JP2007536380A (ja) 2007-12-13
DE602005007485D1 (de) 2008-07-24
AU2005239913A1 (en) 2005-11-17
BRPI0510718A (pt) 2007-11-20
AU2005239913B2 (en) 2011-08-18
ES2306145T3 (es) 2008-11-01
ITRM20040223A1 (it) 2004-08-07
US20080026997A1 (en) 2008-01-31
HK1103961A1 (en) 2008-01-04
PL1750744T3 (pl) 2008-11-28
CA2563400A1 (en) 2005-11-17
EP1750744A1 (en) 2007-02-14
SI1750744T1 (sl) 2008-10-31
EP1750744B1 (en) 2008-06-11
PT1750744E (pt) 2008-08-14
ATE397937T1 (de) 2008-07-15
ME02743B (me) 2010-05-07
CN1950104B (zh) 2010-11-10
WO2005107791A1 (en) 2005-11-17
MXPA06012889A (es) 2007-02-15
KR101192611B1 (ko) 2012-10-18
TW200602075A (en) 2006-01-16
CY1108332T1 (el) 2014-02-12
US8778389B2 (en) 2014-07-15
CN1950104A (zh) 2007-04-18
CA2563400C (en) 2013-07-30

Similar Documents

Publication Publication Date Title
HRP20080413T3 (en) Medicament for the treatment of fungal infections, particularly aspergillosis
NL300936I2 (nl) Semaglutide
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
CL2007003520A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer.
CL2007002167A1 (es) Compuestos derivados de indol, antagonistas iap; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de cancer.
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
BRPI0922435A2 (pt) "composto de tiazolopiridina moduladores de sirtuina, composição farmacêutica compreendendo o mesmo e seu uso."
CL2007003523A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
CL2007002594A1 (es) Compuestos derivados de piridin-3-il, agentes inmunomoduladores; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades asociadas con un sistema inmunologico activado. .
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
CL2012002521A1 (es) Composicion farmaceutica que comprende un inhibidor de dpp iv seleccionado de un grupo definido, un primer diluyente, un segundo diluyente: manitol, un segundo diluyente: almidon pregelatinizado, un aglutinante y un lubricante; util en el tratamiento de diabetes. (divisional de la sol. 1260-07).
CL2007001749A1 (es) Compuesto derivado de 2-arilamino-4-(heterociclo)aminopirimidina, inhibidores de la proteina quinasa c-alfa; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de diabetes, cancer, enfermedad cardiaca coronaria, aterosclerosis, entre otras.
CL2008002369A1 (es) Compuestos derivados de piridin-3-il-oxipiridin-2-il-amino, inhibidores de alk5; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del cancer.
CL2007001734A1 (es) Compuestos derivados de imidazol condensados con heterociclos nitrogenados; composicion farmaceutica; y uso para tratar o prevenir la enfermedad de alzheimer, demencia senil y demencia asociada con enfermedad de parkinson entre otras.
WO2005055973A3 (de) Endoparasitizide mittel zur topischen applikation
NO20053947D0 (no) Forbedrede antitumorale behandlinger.
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
BRPI0608287A2 (pt) agente endoparasiticida
BRPI0500536A (pt) Composição antimicrobiana
UY28344A1 (es) Nuevos compuestos
ATE399532T1 (de) Medizinische seife
NO20075277L (no) Rekombinant uttrykking av defensiner i filamentose sopper
CR9270A (es) Utilizacion de un derivado de pirazol para la preparacion de medicamentos utiles en la prevencion y el tratamiento de enfermedades renales
RU2006107412A (ru) 2,4,6-трифенил-4н-селенопиран-средство для лечения и профилактики отравлений соединениями мышьяка